Nellaxon 2 grams (Ceftriaxone Sodium Hydrate)

Adult administration

Adults and children over 12 years old should receive 1-2g (potency) of ceftriaxone via intravenous or intramuscular injection once daily. In cases of severe diseases or infections caused by moderately susceptible pathogens, the dose can be increased up to 4g (potency) once daily. Elderly patients should follow the same regimen as adults without modification of dosage. A single intramuscular injection of 250mg (potency) is recommended for the treatment of gonorrhea. For infection prevention before and after surgery

Child administration

For neonates (under 14 days old), 20-50mg (potency) per kg of body weight is administered once daily and not exceeding 50mg (potency). For infants and children (15 days to 12 years old), 20-

This medication should not be mixed or administered simultaneously with calcium-containing solutions. It should not be used in newborns, especially those under 28 days old, as the combination with calcium solutions may pose risks. Patients allergic to this medication or those with hypersensitivity to cephalosporins or penicillin antibiotics should not receive it. Additionally, it should not be administered to premature infants or to those with jaundice, hypoalbuminemia, or acidosis. Patients with a history of allergies, severely impaired kidney function, the elderly, and those in poor general condition should use this medication cautiously, and dosage adjustments may be necessary. While using this medication, there is a possibility of various side effects like headaches, dizziness, skin rash, diarrhea, liver function abnormalities, changes in blood cell counts, etc., so if any unusual symptoms occur, medical professionals should be informed immediately. Regular monitoring of liver and kidney functions and blood tests during administration is crucial to detect and address any adverse reactions early. In cases of overdose, there is no specific antidote, so symptomatic treatment is necessary, and caution should be exercised during driving or operating machinery as dizziness may occur. Women who are pregnant or breastfeeding should use this medication cautiously, and it is generally advised not to use it in newborns or premature infants due to the risk of elevated bilirubin levels. This medication may interact with other drugs, so especially when taking diuretics, aminoglycoside antibiotics, vitamin K antagonists, etc., consultation with healthcare professionals is necessary. Finally, this medication should be used only for the minimum duration required for infection treatment to prevent the emergence of resistant strains, and if any adverse reactions or symptoms worsen during administration, healthcare professionals should be notified immediately.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, severe dermatological reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory irregularities accompanied by cough and fever, respiratory issues, yellowing of the skin or eyes (jaundice), profound lethargy, liver abnormalities (jaundice), sudden onset

Mild side effects

• Eosinophilia
• leukopenia
• thrombocytopenia
• diarrhea
• rash
• liver enzyme elevation
• itching
• headache
• dizziness
• nausea

This medication should be stored in a sealed container to prevent air or moisture ingress, and it is recommended to keep it at room temperature between 1°C and 30°C. Proper storage helps maintain the efficacy of the medication and ensures safe usage.

Appearance

A colorless and transparent vial filled with white to pale yellow crystalline powder

Package unit

1 vial X 10